What Is Zepsema? India GLP-1 Guide

A New Option for Weight Management in India

The landscape of weight management and diabetes care is evolving, and new medications are becoming available to patients in India. One such name you may be hearing more about is Zepsema. As a newer treatment option, it’s natural to have questions about what it is, how it works, and who it might be for.

This guide is designed to provide clear, straightforward information about Zepsema, helping you understand its role in health management. It is not a substitute for professional medical advice. Consult your healthcare provider before starting any medication.

Understanding Zepsema and How It Works

What Is Zepsema?

Zepsema is a brand name for the medication semaglutide, listed under Torrent Pharmaceuticals in a March 2026 roundup of semaglutide brands lined up for launch in India after the semaglutide patent expired. Despite the similar-sounding name, it is not tirzepatide (the medicine in Mounjaro and Zepbound).

As of October 2026 we could not find a launch announcement or prescribing information for Zepsema itself. Torrent's announced semaglutide launch on 21 March 2026 was under the brands Sembolic and Semalix. If you have been given a product labelled Zepsema, check the pack and leaflet for its exact form, strength and approved use. Injectable semaglutide is given once a week.

Semaglutide belongs to a class of medications called GLP-1 receptor agonists, which work by mimicking a natural hormone in your body that is involved in regulating blood sugar and appetite. It is intended to be used as part of a broader health plan that includes a balanced diet and increased physical activity.

The Science Behind GLP-1

To understand how Zepsema works, it helps to know about a hormone your gut produces after you eat: GLP-1 (glucagon-like peptide-1).

This hormone plays several key roles:

• It signals the pancreas to release insulin when blood sugar levels are high.
• It can slow down how quickly food leaves your stomach, which helps you feel full for longer.
• It acts on parts of the brain that control appetite and food intake.

Semaglutide activates the same GLP-1 receptors but lasts much longer in the body than natural GLP-1, which is why injectable semaglutide only needs to be given once a week. These actions are the reason it is used both for blood sugar control and for weight management.

Who Might Be a Candidate for Zepsema?

Zepsema is a prescription medication, meaning a qualified doctor must determine if it is an appropriate treatment for you based on your individual health profile.

Approved Uses

Semaglutide is approved for two main purposes, but each brand has its own approved uses, and in India some brands are approved only for type 2 diabetes. Ask your doctor which applies to the product you are prescribed:

1. Type 2 Diabetes: It can be used to improve blood sugar (glycemic) control in adults with type 2 diabetes, used in conjunction with diet and exercise.
2. Chronic Weight Management: Some semaglutide products are approved for adults with obesity (a Body Mass Index, or BMI, of 30 or more) or who are overweight (BMI of 27 or more) and have at least one weight-related health condition, such as high blood pressure, high cholesterol, or type 2 diabetes.

It's Not a Quick Fix

It is essential to understand that medications like Zepsema are tools, not standalone cures. They are most effective when integrated into a comprehensive lifestyle plan. Sustainable health improvements come from a combination of medical treatment, nutritional changes, and consistent physical activity. Your doctor will likely discuss creating a holistic plan that addresses these key areas to help you achieve and maintain your health goals.

The journey toward better health is a partnership between you and your healthcare team, and a platform like Weight Easy can support you with evidence-based information on your path.

What to Expect: The Practical Side of Treatment

Starting any new medication involves learning a new routine. Understanding the practical aspects can help make the process smoother.

How Is Zepsema Administered?

Zepsema is a subcutaneous injection, which means it is injected into the fatty tissue just under the skin. It is designed to be self-administered once a week, on the same day each week. Common injection sites include the abdomen, the thigh, or the back of the upper arm.

Your doctor or a nurse will provide detailed instructions and training on how to properly use the injection pen, ensuring you feel confident and safe administering it at home. The needles are very fine, and most people find the process to be quick and relatively painless.

Potential Side Effects

Like all medications, Zepsema can cause side effects. The most common ones are related to the digestive system and include:

• Nausea
• Diarrhoea
• Vomiting
• Constipation
• Decreased appetite
• Abdominal pain

These side effects are often mild to moderate and tend to be most noticeable when first starting the medication or after a dose increase. For many people, they lessen over time as their body adjusts. It's important to report any side effects to your doctor, especially if they are severe or persistent.

When to get medical help

Contact your doctor promptly if nausea, vomiting or diarrhoea stop you keeping fluids down, or if you notice signs of dehydration such as dizziness or passing very little urine, because fluid loss can affect the kidneys. Get urgent medical help for severe stomach pain that does not go away (it may spread to your back, with or without vomiting), which can be a sign of pancreatitis; pain in the upper right side of your stomach, fever, or yellowing of the skin or eyes, which can point to gallbladder problems; or swelling of the face, lips or throat or trouble breathing, which can be a serious allergic reaction. If you also take insulin or a sulfonylurea, ask your prescriber how to recognise and treat low blood sugar.

Important Conversations with Your Doctor

An open and honest dialogue with your healthcare provider is the most important step in considering any new treatment. Here are some key topics to discuss before starting Zepsema.

Your Health History

Be prepared to share your complete medical history. It is crucial for your doctor to know if you or any family members have a history of certain conditions, such as:

• Pancreatitis
• Kidney problems
• Severe stomach or digestive issues
• Medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), in which case semaglutide should not be used
• Gallbladder disease or diabetic eye disease (retinopathy)

Also tell your doctor if you are pregnant, planning a pregnancy or breastfeeding, and tell any doctor planning surgery or sedation that you take it.

Other Medications

Provide your doctor with a full list of all other medications you take, including prescription drugs, over-the-counter medicines, vitamins, and herbal supplements. This helps prevent any potential drug interactions. Taking semaglutide with insulin or a sulfonylurea raises the risk of low blood sugar.

Setting Realistic Goals

Talk to your doctor about your health goals and what success looks like for you. This could be related to a specific weight target, improved blood sugar levels, or simply feeling better and having more energy. Setting realistic expectations is key to a positive and motivated journey.

A Tool, Not a Magic Bullet

Zepsema is a brand of semaglutide, a medicine used in the management of type 2 diabetes and chronic weight management. It can be a useful tool for improving metabolic health when combined with a commitment to a healthier lifestyle.

However, the decision to start this or any medication is a personal one that should be made in close partnership with a trusted medical professional who understands your unique health needs. Consult your healthcare provider before starting any medication.

Sources

• Central Drugs Standard Control Organisation (CDSCO), India: https://cdsco.gov.in/opencms/opencms/en/Home/
• Medical Dialogues, India semaglutide brand list (4 March 2026): https://medicaldialogues.in/news/industry/pharma/indias-semaglutide-market-set-for-generic-boom-as-patents-expire-over-50-brands-lined-up-for-launch-see-full-list-165838
• Torrent Pharmaceuticals semaglutide launch release (21 March 2026): https://www.torrentpharma.com/docs/Press_Release_a634006544.pdf
• Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1 trial), New England Journal of Medicine: https://pubmed.ncbi.nlm.nih.gov/33567185/
• Obesity and Overweight Fact Sheet, World Health Organization: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight
• Ozempic (semaglutide) US prescribing information: https://www.novo-pi.com/ozempic.pdf
• Wegovy (semaglutide) US prescribing information: https://www.novo-pi.com/wegovy.pdf